FREE TRIAL - NO CARD NEEDED
Pubrio gives your team the data, timing, and tools to reach the right prospects before the competition does.
Company & people search
Filter 560M+ contacts by role, industry, tech stack & more.
Sequences
Automate multi-step outreach without losing the personal touch.
Market signals
Stay ahead of every market shift. Pubrio Signals watches companies for you and delivers the right intelligence.
Start your free trial
Join 9,000+ revenue teams already using Pubrio.
No credit card · Cancel anytime · GDPR safe
Already have an account?Log in
United Kingdom · Research
Research
Pharmaceuticals
Biotechnology
Information Technology
PharmEnable Therapeutics is a spin-out from the University of Cambridge, UK, focused on re-imagining small molecule therapeutics through AI. They aim to unlock novel chemical spaces by using AI-enabled drug discovery to target challenging and data-sparse areas in medicine, creating innovative first- and best-in-class drugs.
2016
Founded
Research
Industry
United Kingdom
Location
9,066,331
Ranking
16 employees
Size
Get full access to view complete information
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© Pubrio 2026
